Drawing for DAZAX

USPTO serial 76355455

DAZAX

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
BROWN, BRIAN
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with DAZAX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

LAWRENCE E. ABELMAN

LAWRENCE E ABELMAN ABELMAN, FRAYNE & SCHWAB666 3RD AVENEW YORK, NY 10017-5612UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Humanized monoclonal antibody against respiratory syncytial virus for scientific research useACTIVE—
005Humanized monoclonal antibody against respiratory syncytial virus for medical clinical useACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 7, 2006CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Feb 7, 2006MAILPAPER RECEIVED—
Nov 16, 2005MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Nov 16, 2005ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Mar 29, 2005EX5GSOU EXTENSION 5 GRANTED—
Mar 4, 2005EXT5SOU EXTENSION 5 FILED—
Mar 4, 2005EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 9, 2004EX4GSOU EXTENSION 4 GRANTED—
Aug 26, 2004EXT4SOU EXTENSION 4 FILED—
Aug 26, 2004EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 30, 2004CFITCASE FILE IN TICRS—
Jun 24, 2004MAILPAPER RECEIVED—
Mar 19, 2004EX3GSOU EXTENSION 3 GRANTED—
Mar 8, 2004MAILPAPER RECEIVED—
Mar 4, 2004EXT3SOU EXTENSION 3 FILED—
Oct 7, 2003EX2GSOU EXTENSION 2 GRANTED—
Sep 11, 2003MAILPAPER RECEIVED—
Sep 9, 2003EXT2SOU EXTENSION 2 FILED—
May 15, 2003EX1GSOU EXTENSION 1 GRANTED—
Mar 10, 2003EXT1SOU EXTENSION 1 FILED—
Sep 10, 2002NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jun 18, 2002PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 29, 2002NPUBNOTICE OF PUBLICATION—
Mar 25, 2002CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 22, 2002DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance